Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report

Bilateral uveitis associated with nivolumab therapy for metastatic melanoma: a case report

Bibliographic Details
Main Authors:	Daniel Russell Richardson, Brian Ellis, Inderjit Mehmi, Monique Leys
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2017-07-01
Series:	International Journal of Ophthalmology
Subjects:	1186
Online Access:	http://www.ijo.cn/en_publish/2017/7/20170728.pdf

Similar Items

Solutions for Small Farmers and Home Gardens: Building a Low-Cost Vertical Soilless System for Production of Small Vegetable and Fruit Crops
by: Bielinski M. Santos, et al.
Published: (2010-11-01)

Ahorre dinero en la tienda de comestibles
by: Glenda L. Warren, et al.
Published: (2010-08-01)

A new behavioral principle for urban transportation networks
Published: (2002)

Bilateral Vitiligo-Like Depigmentation of Choroid and Retinal Pigment Epithelium Associated with Ipilimumab-Nivolumab Therapy for Metastatic Cutaneous Melanoma
by: Caroline C. Cotton, et al.
Published: (2024-01-01)

Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
by: Shumpei Obata, et al.
Published: (2019-02-01)

Estimated Costs of the Ipilimumab–Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma
by: Bianca Gautron Moura, et al.
Published: (2022-12-01)

Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients
by: Ronen Stoff, et al.
Published: (2022-11-01)

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
by: Nethanel Asher, et al.
Published: (2020-08-01)

Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
by: Nanumi Han, et al.
Published: (2018-03-01)

Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report
by: Alyssa R. Cruse, et al.
Published: (2023-10-01)

Bilateral Optic Neuritis Secondary to Nivolumab Therapy: A Case Report
by: Ömer Kartal, et al.
Published: (2018-11-01)

Case Report: Thrombotic-Thrombocytopenic Purpura Following Ipilimumab and Nivolumab Combination Immunotherapy for Metastatic Melanoma
by: W. J. Mullally, et al.
Published: (2022-04-01)

The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
by: Domenico Mallardo, et al.
Published: (2023-10-01)

Severe Gastritis Due to Nivolumab Treatment of a Metastatic Melanoma Patient
by: George Samonis, et al.
Published: (2022-11-01)

Some aspects of nivolumab administration in treatment for metastatic melanoma (clinical cases)
by: L. Yu. Vladimirova, et al.
Published: (2021-08-01)

Complete regression of metastatic malignant melanoma endoscopically after nivolumab administration
by: Dae Gon Ryu, et al.
Published: (2021-11-01)

Regression of Multiple Melanocytic Nevi in Two Patients on Nivolumab for Metastatic Melanoma
by: Gloria Baeza-Hernández, et al.
Published: (2023-01-01)

Autoimmune myositis and myasthenia gravis resulting from a combination therapy with nivolumab and ipilimumab for metastatic melanoma
by: Ravi Sutaria, et al.
Published: (2019-07-01)

Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
by: Koji Nakajima, et al.
Published: (2021-10-01)

Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
by: Sophia Wix, MPhil, et al.
Published: (2023-08-01)

Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data
by: Theodoros G. Soldatos, et al.
Published: (2018-10-01)

Bilateral Uveitis in Silent Ulcerative Colitis: Case Report
by: Saba Hussein Alwais, et al.
Published: (2023-03-01)

Occurrence of Fatal Tubulopathy in an Old, Fit Patient Receiving Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report
by: Marine Georgery, et al.
Published: (2024-02-01)

Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma
by: Lukas Kraehenbuehl, et al.
Published: (2022-05-01)

Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations
by: Lucía Vázquez-Montero, et al.
Published: (2023-06-01)

Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma
by: Veronica Aedo-Lopez, et al.
Published: (2022-02-01)

A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy
by: Keisuke Minami, et al.
Published: (2021-12-01)

Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report
by: Selina Reiter, et al.
Published: (2023-05-01)

A Case of Nivolumab-induced Hypophysitis in a 72-year-old Female with Metastatic Melanoma
by: Vikhyathi Pallerla, MS, et al.
Published: (2023-12-01)

Bilateral Posterior Uveitis Due to Syphilis
by: Ali Ilgın OLUT, et al.
Published: (2018-12-01)

A Dramatic Response to Second-Line Nivolumab and Ipilimumab in BRAF-V600-Mutated Metastatic Melanoma
by: Dahlia Fedele, et al.
Published: (2024-01-01)

Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience
by: Renata Pacholczak-Madej, et al.
Published: (2022-10-01)

Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients
by: Hélène Salaün, et al.
Published: (2022-12-01)

Complete and Durable Response After Radiation Therapy to Primary Tumor Site of a Patient With Metastatic Anorectal Mucosal Melanoma With Oligoprogression on Nivolumab
by: David G. Wallington, MS, et al.
Published: (2020-05-01)

699 Phase 2 trial of brentuximab vedotin (BV) with pembrolizumab (pembro) in patients with metastatic non-small cell lung cancer or metastatic cutaneous melanoma after progression on anti-PD-1 therapy
by: Omid Hamid, et al.
Published: (2023-11-01)

The adjuvant treatment role of ω-3 fatty acids by regulating gut microbiota positively in the acne vulgaris
by: Yaxin Huang, et al.
Published: (2024-12-01)

A Case of Acute Bilateral Syphilitic Uveitis
by: Dorukcan Akıncıoğlu, et al.
Published: (2015-05-01)

Bilateral Anterior Uveitis Revealing Relapsing Polychondritis
by: Murat Hasanreisoğlu, et al.
Published: (2019-04-01)

Efficacy of Abatacept Therapy in a Patient with Juvenile Idiopathic Arthritis and Bilateral Uveitis
by: Lelia A. Galstian, et al.
Published: (2016-08-01)

Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma
by: Takuya Segawa, et al.
Published: (2023-03-01)